ASBP
Aspire Biopharma Holdings, Inc.
Biopharmaceutical company developing patent-protected sublingual drug delivery technology; completed merger with PowerUp Acquisition Corp (SPAC) on February 17, 2025; began trading as ASBP on February 20, 2025
CUSIP: G7207P111HealthcareUS1 holder
Total Value
$3.02M
Total Shares
300.0K
Net Share Change
+300.0K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Oaktree Capital Management
$3.02M300.0K sharesNEW